Malignant pleural mesothelioma (MPM) is an aggressive primary malignancy of the pleura
that presents unique radiologic challenges with regard to accurate and reproducible …

Malignant mesothelioma is an aggressive tumor originating from the mesothelial cells and
presenting in general with a very poor prognosis. The pleural localization represents the …

A diverse spectrum of benign entities and malignant neoplasms originate from the
monotonous mesothelium that lines the serosal membranes of the pleural, pericardial, and …

The fibroblast activation protein (FAP) is highly expressed in tumor and stromal cells of
mesothelioma and thus is an interesting imaging and therapeutic target. Previous data on …

Malignant pleural mesothelioma is a rare type of cancer, whose incidence, however, is
increasing and will presumably continue to rise in the coming years. Key features of this …

A 50-year-old man presented with cough and hemoptysis for 1 month. Chest CT showed an
irregular mass in the right lung, with enlarged lymph nodes in the mediastinum and right …

Objective We conducted a prospective study using 18F-flurodeoxyglucose (18F-FDG) and
68Ga-DOTA-FAPI-04 (fibroblast-activation protein inhibitor, 68Ga-FAPI) PET/CT to …

Malignant peritoneal mesothelioma is a rare malignancy that may manifest as
extraperitoneal metastasis. We describe the findings of 68 Ga-FAPI and 18 F-FDG PET/CT in …

Mesothelioma is a malignant tumor associated primarily with asbestos exposure,
characterized by an aggressive nature and poor prognosis. Accurate diagnosis, staging, and …

We describe 68 Ga-FAPI (fibroblast activation protein inhibitor)-04 and 18 F-FDG PET/CT
findings in a case with epithelioid malignant pleural mesothelioma. Compared with 18 F …